Dr. Mizrahi has deep expertise in synthetic biology and RNA editing mechanisms, and leads antibody expression research and development at GigaGen. Prior to GigaGen she held research positions at Genentech, DuPont Industrial Biosciences (Genencor) and Lawrence Berkeley National Laboratory. Dr. Mizrahi holds a B.S. in Chemistry from Washington University in St. Louis and a Ph.D. in Chemistry with a Designated Emphasis in Biotechnology from the University of California, Davis, where she was also a National Science Foundation Graduate Research Fellow. Most recently, Dr. Mizrahi was named as one of the Most Influential Women in Business for 2020 by the San Francisco Business Times.